
Overview
Funda Meric is a General Surgeon and a Surgical Oncologist practicing medicine in Houston, Texas.
Dr. Meric is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Triple-Negative Breast Cancer, and Mastectomy.
She is actively involved in clinical research, co-authoring 572 peer reviewed articles and participating in 24 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life Sciences Plaza, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
24 Clinical Trials
Baylor St. Luke's - O’Quinn Medical Tower At McNair
Dr. Alastair Thompson is a surgical oncologist specializing in breast cancer. He is the Professor and Chief of the Division of Surgical Oncology, Section of Breast Surgery at Baylor College of Medicine, where he holds the Olga Keith Wiess Chair of Surgery. He also serves as Co-Director of the Lester and Sue Smith Breast Center and is Co-Associate Director for Clinical Research at the Dan L Duncan Comprehensive Cancer Center.Dr. Thomspon’s clinical interests include: ductal carcinoma in situ (DCIS); nipple and skin sparing mastectomy; breast conservation surgery; and sentinel lymph node biopsy. His research interests include: multidisciplinary patient care alongside “bench to bedside” studies; and innovative clinical trials in cancer. He initiated and led a successful breast cancer laboratory program; provided leadership for a cancer center in the United Kingdom; chaired the UK national breast cancer trials portfolio of 120 studies; and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, United States and Australia.Dr. Thompson also has preclinical and practical experience in the design, implementation, monitoring and reporting of early- to late-phase drug and medical device trials. Dr. Thompson received his MBChB in Medicine Surgery and medical degree in Molecular Biology from the University of Edinburgh in Edinburgh, Scotland. He completed his residency in general surgery at the Royal Infirmary of Edinburgh and a Research Fellowship at the Imperial Cancer Research Fund in Edinburgh.Dr. Thompson has co-chaired the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low-risk DCIS; and the National Cancer Institute (NCI)-Breast Cancer Steering Committee proposed “no surgery” clinical trial planning committee. He is a member of the NCI BOLD taskforce and has held leadership positions in the Translational Breast Cancer Research Consortium and SWOG Cancer Research Network.Dr. Thompson is also a member of the American Society of Clinical Oncology, Association of Breast Surgery, British Association of Surgical Oncology, British Breast Group, American Society of Breast Surgeons, American Association for Cancer Research, Moynihan Chirurgical Club, and the Society of Surgical Oncology. Dr. Thompson is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Tissue Biopsy. Dr. Thompson is currently accepting new patients.
UT MD Anderson Cancer Center
Naruhiko Ikoma is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Ikoma is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Gastrectomy, and Pancreaticoduodenectomy.
Thomas Aloia is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Aloia is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Gallbladder Adenocarcinoma, Hepatectomy, and Hepato-Pancreato-Biliary Surgery.
Frequently Asked Questions about Dr. Funda Meric
How do I make an appointment with Dr. Funda Meric?
You can book an appointment with Dr. Funda Meric by calling their office at 713-592-5433. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Funda Meric a top-rated expert for PIK3CA-Related Overgrowth Spectrum?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Funda Meric is classified as an Elite expert for PIK3CA-Related Overgrowth Spectrum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Funda Meric specialize in?
While Dr. Funda Meric is a General Surgery, they have specific expertise in PIK3CA-Related Overgrowth Spectrum, Breast Cancer, and Cholangiocarcinoma (Bile Duct Cancer). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.
Does Dr. Funda Meric participate in research or clinical trials?
Yes. Dr. Funda Meric has published 571 articles and abstracts on conditions like PIK3CA-Related Overgrowth Spectrum. You can view a list of Dr. Funda Meric's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Funda Meric accept my insurance?
Dr. Funda Meric accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-592-5433 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Meric isElite. Learn about Breast Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- PIK3CA-Related Overgrowth Spectrum
- Distinguished
- Adult Soft Tissue SarcomaDr. Meric isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Colorectal CancerDr. Meric isDistinguished. Learn about Colorectal Cancer.
- MastectomyDr. Meric isDistinguished. Learn about Mastectomy.
- MelanomaDr. Meric isDistinguished. Learn about Melanoma.
- Pancreatic CancerDr. Meric isDistinguished. Learn about Pancreatic Cancer.
- Triple-Negative Breast CancerDr. Meric isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- Familial Pancreatic CancerDr. Meric isAdvanced. Learn about Familial Pancreatic Cancer.
- Gallbladder CancerDr. Meric isAdvanced. Learn about Gallbladder Cancer.
- HER-2 Positive Breast CancerDr. Meric isAdvanced. Learn about HER-2 Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Meric isAdvanced. Learn about HER2 Negative Breast Cancer.
- Inflammatory Breast CancerDr. Meric isAdvanced. Learn about Inflammatory Breast Cancer.
- Neuroendocrine TumorDr. Meric isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- Adrenal CancerDr. Meric isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Meric isExperienced. Learn about Adrenocortical Carcinoma.
- Alveolar Soft Part SarcomaDr. Meric isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Meric isExperienced. Learn about Anal Cancer.
- Anaplastic Thyroid CancerDr. Meric isExperienced. Learn about Anaplastic Thyroid Cancer.
- AngiosarcomaDr. Meric isExperienced. Learn about Angiosarcoma.
